In last trading session, Tenaya Therapeutics Inc (NASDAQ:TNYA) saw 2.66 million shares changing hands with its beta currently measuring 3.00. Company’s recent per share price level of $0.69 trading at $0.04 or 5.60% at ring of the bell on the day assigns it a market valuation of $112.24M. That closing price of TNYA’s stock is at a discount of -488.41% from its 52-week high price of $4.06 and is indicating a premium of 47.83% from its 52-week low price of $0.36.

For Tenaya Therapeutics Inc (TNYA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information

Tenaya Therapeutics Inc’s shares saw a change of -77.88% in year-to-date performance and have moved 20.21% in past 5-day. Tenaya Therapeutics Inc (NASDAQ:TNYA) showed a performance of 60.32% in past 30-days.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -15.48% during past 5 years.

Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders

COLUMN GROUP LLC is the top institutional holder at TNYA for having 9.4 million shares of worth $29.14 million. And as of 2024-06-30, it was holding 10.968 of the company’s outstanding shares.

The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 7.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8935 of outstanding shares, having a total worth of $23.63 million.